AIM
NVO

Advantage Investment Management’s Novo Nordisk NVO Stock Holding History

Advantage Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$16K Sell
600
-24
-4% -$607 0.01% 568
2019
Q2 		$16K Hold
624
– – 0.01% 578
2019
Q1 		$16K Buy
624
+74
+13% +$1.82K 0.01% 567
2018
Q4 		$13K Buy
550
+342
+164% +$7.6K 0.01% 600
2018
Q3 		$5K Sell
208
-64
-24% -$1.56K ﹤0.01% 848
2018
Q2 		$6K Sell
272
-698
-72% -$16.6K ﹤0.01% 740
2018
Q1 		$24K Hold
970
– – 0.01% 521
2017
Q4 		$26K Sell
970
-70
-7% -$1.78K 0.01% 531
2017
Q3 		$25K Sell
1,040
-446
-30% -$10.1K 0.01% 514
2017
Q2 		$32K Sell
1,486
-658
-31% -$13.3K 0.01% 480
2017
Q1 		$37K Buy
2,144
+700
+48% +$12.2K 0.01% 423
2016
Q4 		$26K Buy
1,444
+430
+42% +$7.79K 0.01% 462
2016
Q3 		$21K Buy
1,014
+430
+74% +$10.7K 0.01% 494
2016
Q2 		$16K Sell
584
-412
-41% -$11.3K 0.01% 505
2016
Q1 		$27K Sell
996
-56
-5% -$1.5K 0.01% 418
2015
Q4 		$31K Buy
1,052
+300
+40% +$8.3K 0.02% 403
2015
Q3 		$20K Buy
752
+186
+33% +$5.27K 0.01% 449
2015
Q2 		$16K Buy
566
+128
+29% +$3.6K 0.01% 513
2015
Q1 		$12K Buy
+438
New +$10.1K 0.01% 552

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Advantage Investment Management's NVO Position: Q3 2019 in Review

Advantage Investment Management reduced its Novo Nordisk (NVO) stake by 3.8% in Q3 2019, selling an estimated $607 and leaving 600 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #568.

Advantage Investment Management first reported a position in NVO in Q1 2015 and has held it in 19 quarters since. The position peaked at $37K in Q1 2017. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • Advantage Investment Management held 600 shares of Novo Nordisk worth $16K as of Q3 2019.
  • Advantage Investment Management sold 24 Novo Nordisk shares in Q3 2019, an estimated $607.
  • Novo Nordisk made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #568 holding.
  • Advantage Investment Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 19 quarters since.
  • Advantage Investment Management's Novo Nordisk position peaked at $37K in Q1 2017.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.